Publication:
Epidemiology and burden of multidrug-resistant bacterial infection in a developing country

dc.contributor.authorCherry Limen_US
dc.contributor.authorEmi Takahashien_US
dc.contributor.authorMaliwan Hongsuwanen_US
dc.contributor.authorVanaporn Wuthiekanunen_US
dc.contributor.authorVisanu Thamlikitkulen_US
dc.contributor.authorSoawapak Hinjoyen_US
dc.contributor.authorNicholas P.J. Dayen_US
dc.contributor.authorSharon J. Peacocken_US
dc.contributor.authorDirek Limmathurotsakulen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherLondon School of Hygiene & Tropical Medicineen_US
dc.contributor.otherUniversity of Cambridgeen_US
dc.date.accessioned2018-12-11T02:09:03Z
dc.date.accessioned2019-03-14T08:04:01Z
dc.date.available2018-12-11T02:09:03Z
dc.date.available2019-03-14T08:04:01Z
dc.date.issued2016-09-06en_US
dc.description.abstract© Lim et al. Little is known about the excess mortality caused by multidrug-resistant (MDR) bacterial infection in low- and middle-income countries (LMICs). We retrospectively obtained microbiology laboratory and hospital databases of nine public hospitals in northeast Thailand from 2004 to 2010, and linked these with the national death registry to obtain the 30-day mortality outcome. The 30-day mortality in those with MDR community-acquired bacteraemia, healthcareassociated bacteraemia, and hospital-acquired bacteraemia were 35% (549/1555), 49% (247/500), and 53% (640/1198), respectively. We estimate that 19,122 of 45,209 (43%) deaths in patients with hospital-acquired infection due to MDR bacteria in Thailand in 2010 represented excess mortality caused by MDR. We demonstrate that national statistics on the epidemiology and burden of MDR in LMICs could be improved by integrating information from readily available databases. The prevalence and mortality attributable to MDR in Thailand are high. This is likely to reflect the situation in other LMICs.en_US
dc.identifier.citationeLife. Vol.5, No.September (2016)en_US
dc.identifier.doi10.7554/eLife.18082en_US
dc.identifier.issn2050084Xen_US
dc.identifier.other2-s2.0-84988527741en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/42969
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84988527741&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.titleEpidemiology and burden of multidrug-resistant bacterial infection in a developing countryen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84988527741&origin=inwarden_US

Files

Collections